News Snapshot:
1. Topical application of ON101, a macrophage regulator cream, demonstrated superior therapeutic efficacy in the treatment of diabetic foot ulcers compared to standard absorbent dressing in terms of both complete healing rate and time to complete healing. 2. Therapeutic efficacy of ON101 was sustained in patients with high-risk factors including ulcers that last for more than 6 months, measure greater than 5 cm2, or in patients with high HbA1c levels. 1 (Excellent) Study Rundown: Diabetic foot ulcers (DFUs) are a common complication of chronic diabetes. Current standard treatments focus mainly on local wound care, including debridement, off-loading, infection control, and...
